An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology

Overview

Journal J Cardiovasc Dev Dis

Specialty Cardiology & Vascular Diseases

Date 2019 Apr 3

PMID 30934934

Citations 124

Authors

Ali Nehme

Fouad A Zouein

Zeinab Deris Zayeri

Kazem Zibara

Affiliations

Soon will be listed here.

Abstract

In its classical view, the renin angiotensin system (RAS) was defined as an endocrinesystem involved in blood pressure regulation and body electrolyte balance. However, the emergingconcept of tissue RAS, along with the discovery of new RAS components, increased thephysiological and clinical relevance of the system. Indeed, RAS has been shown to be expressed invarious tissues where alterations in its expression were shown to be involved in multiple diseasesincluding atherosclerosis, cardiac hypertrophy, type 2 diabetes (T2D) and renal fibrosis. In thischapter, we describe the new components of RAS, their tissue-specific expression, and theiralterations under pathological conditions, which will help achieve more tissue- and conditionspecifictreatments.

Citing Articles

Renal Function and the Role of the Renin-Angiotensin-Aldosterone System (RAAS) in Normal Pregnancy and Pre-Eclampsia.

Tsikouras P, Nikolettos K, Kotanidou S, Kritsotaki N, Oikonomou E, Bothou A J Clin Med. 2025; 14(3).

PMID: 39941563 PMC: 11818630. DOI: 10.3390/jcm14030892.

Optimization of Ultrasound Extraction of Total Anthocyanin From Rupr. by Response Surface Methodology and Its Antihypertensive Effect.

Khan N, Yusufu M, Ahmadova Z, Maihemuti N, Hailati S, Talihat Z Food Sci Nutr. 2024; 12(12):10699-10715.

PMID: 39723043 PMC: 11666821. DOI: 10.1002/fsn3.4591.

(Huds.) Opiz Exhibits Antihypertensive Effects by Inhibiting the Angiotensin-Converting Enzyme/Angiotensin II Type 1 Receptor Pathway in Human Endothelial Cells.

Othman N, Hisam N, Mad Azli A, Mansor N, A Hamid A, Aminuddin A Life (Basel). 2024; 14(11).

PMID: 39598284 PMC: 11595449. DOI: 10.3390/life14111486.

Cardiometabolic Aspects of Congenital Adrenal Hyperplasia.

Krysiak R, Claahsen-van der Grinten H, Reisch N, Touraine P, Falhammar H Endocr Rev. 2024; 46(1):80-148.

PMID: 39240753 PMC: 11720181. DOI: 10.1210/endrev/bnae026.

First-in-human study evaluating safety, pharmacokinetics, and pharmacodynamics of lorundrostat, a novel and highly selective aldosterone synthase inhibitor.

Shimizu H, Tortorici M, Ohta Y, Ogawa K, Rahman S, Fujii A Clin Transl Sci. 2024; 17(8):e70000.

PMID: 39152532 PMC: 11329366. DOI: 10.1111/cts.70000.

References

Rakoczy P, Sarks S, Daw N, Constable I . Distribution of cathepsin D in human eyes with or without age-related maculopathy. Exp Eye Res. 1999; 69(4):367-74. DOI: 10.1006/exer.1999.0700. View

Nouet S, Nahmias C . Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab. 2000; 11(1):1-6. DOI: 10.1016/s1043-2760(99)00205-2. View

Kim S, Iwao H . Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000; 52(1):11-34. View

Handa R . Metabolism alters the selectivity of angiotensin-(1-7) receptor ligands for angiotensin receptors. J Am Soc Nephrol. 2000; 11(8):1377-1386. DOI: 10.1681/ASN.V1181377. View

Tipnis S, Hooper N, Hyde R, Karran E, Christie G, Turner A . A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000; 275(43):33238-43. DOI: 10.1074/jbc.M002615200. View

Caruso-Neves C, Lara L, Rangel L, Grossi A, Lopes A . Angiotensin-(1-7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule. Biochim Biophys Acta. 2000; 1467(1):189-97. DOI: 10.1016/s0005-2736(00)00219-4. View

Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N . A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000; 87(5):E1-9. DOI: 10.1161/01.res.87.5.e1. View

de Gasparo M, Catt K, Inagami T, Wright J, Unger T . International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000; 52(3):415-72. View

Carey R, Wang Z, Siragy H . Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation. Curr Hypertens Rep. 2000; 2(2):198-201. DOI: 10.1007/s11906-000-0082-3. View

10.

Arakawa K, Urata H . Hypothesis regarding the pathophysiological role of alternative pathways of angiotensin II formation in atherosclerosis. Hypertension. 2000; 36(4):638-41. DOI: 10.1161/01.hyp.36.4.638. View

11.

Belova L . Angiotensin II-generating enzymes. Biochemistry (Mosc). 2001; 65(12):1337-45. DOI: 10.1023/a:1002848402911. View

12.

Saris J, Derkx F, de Bruin R, Dekkers D, Lamers J, Saxena P . High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol. 2001; 280(4):H1706-15. DOI: 10.1152/ajpheart.2001.280.4.H1706. View

13.

van Kats J, van Meegen J, Verdouw P, Duncker D, SCHALEKAMP M, Danser A . Subcellular localization of angiotensin II in kidney and adrenal. J Hypertens. 2001; 19(3 Pt 2):583-9. DOI: 10.1097/00004872-200103001-00010. View

14.

Albiston A, McDowall S, Matsacos D, Sim P, Clune E, Mustafa T . Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem. 2001; 276(52):48623-6. DOI: 10.1074/jbc.C100512200. View

15.

Lara L, Bica R, Sena S, Correa J, Lopes A, Caruso-Neves C . Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor. Regul Pept. 2001; 103(1):17-22. DOI: 10.1016/s0167-0115(01)00322-6. View

16.

Cesari M, Rossi G, Pessina A . Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J Hypertens. 2002; 20(5):793-9. DOI: 10.1097/00004872-200205000-00002. View

17.

Jackman H, Massad M, Sekosan M, Tan F, Brovkovych V, Marcic B . Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension. 2002; 39(5):976-81. DOI: 10.1161/01.hyp.0000017283.67962.02. View

18.

Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J . Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002; 109(11):1417-27. PMC: 150992. DOI: 10.1172/JCI14276. View

19.

Arakawa K, Ikeda M, Fukuyama J, Sakai T . A pressor formation by trypsin from renin-denatured human plasma protein. J Clin Endocrinol Metab. 1976; 42(3):599-602. DOI: 10.1210/jcem-42-3-599. View

20.

Tom B, Dendorfer A, Danser A . Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?. Int J Biochem Cell Biol. 2003; 35(6):792-801. DOI: 10.1016/s1357-2725(02)00273-x. View